[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - August 2004

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 77-011 ONDANSETRON INJECTION USP (PRESERVATIVE-FREE) 2 MG (BASE)/ML, PACKAGED IN 4 MG (BASE)/2 ML SINGLE-DOSE VIALS   BEDFORD LABORATORIES 8/11/2004 
2 76-967 ONDANSETRON INJECTION, USP 2 MG (BASE)/ML, PACKAGED IN 40 MG (BASE)/20 ML MULTIPLE-DOSE VIALS   BEDFORD LABORATORIES 8/11/2004 
3 76-671 SERTRALINE HYDROCHLORIDE TABLETS 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   MYLAN PHARMACEUTICALS INC. 8/12/2004 
4 76-677 CETIRIZINE HYDROCHLORIDE TABLETS 5 MG AND 10 MG   MYLAN PHARMACEUTICALS, INC. 8/20/2004 
5 76-606 GABAPENTIN CAPSULES 100 MG, 300 MG, AND 400 MG   RANBAXY LABORATORIES LIMITED 8/25/2004 
6 76-693 ONDANSETRON ORALLY DISINTEGRATING TABLETS 4 MG AND 8 MG   BARR LABORATORIES, INC. 8/26/2004 

Back to Top     Back to Approvals

Date created: September 8, 2004

horizonal rule